Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
3,601 questions in 252 reviews · Pregnancy and Childbirth
current versionsNo studies 726 · 20.2%Ungraded 421 · 11.7%Very low 828 · 23%Low 993 · 27.6%Moderate 486 · 13.5%High 147 · 4.1%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Summary of findings table ‐ Moxibustion plus usual care vs sham moxibustion plus usual care Caesarean section · breech presentation Cephalic version by moxibustion for breech presentation (2023) · Cochrane | RR 0.84 [0.68, 1.04] | 1 study · 272 participants | Moderate |
Summary of findings table ‐ Moxibustion plus usual care vs sham moxibustion plus usual care Premature rupture of membranes ‐ not reported · breech presentation Cephalic version by moxibustion for breech presentation (2023) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Moxibustion plus usual care vs sham moxibustion plus usual care Use of oxytocin ‐ not reported · breech presentation Cephalic version by moxibustion for breech presentation (2023) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Moxibustion plus usual care vs sham moxibustion plus usual care Cord blood pH < 7.1 ‐ not reported · breech presentation Cephalic version by moxibustion for breech presentation (2023) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Moxibustion plus usual care vs sham moxibustion plus usual care Adverse events · breech presentation Cephalic version by moxibustion for breech presentation (2023) · Cochrane | no estimate extracted | 1 study · 272 participants | Ungraded |
Summary of findings table ‐ Moxibustion plus usual care vs usual care Need for ECV · breech presentation Cephalic version by moxibustion for breech presentation (2023) · Cochrane | RR 0.62 [0.32, 1.21] | 4 studies · 692 participants | Low |
Summary of findings table ‐ Moxibustion plus usual care vs usual care Caesarean section · breech presentation Cephalic version by moxibustion for breech presentation (2023) · Cochrane | RR 0.94 [0.83, 1.05] | 6 studies · 1030 participants | Moderate |
Summary of findings table ‐ Moxibustion plus usual care vs usual care Premature rupture of membranes · breech presentation Cephalic version by moxibustion for breech presentation (2023) · Cochrane | RR 1.31 [0.17, 10.21] | 3 studies · 402 participants | Low |
Summary of findings table ‐ Moxibustion plus usual care vs usual care Use of oxytocin · breech presentation Cephalic version by moxibustion for breech presentation (2023) · Cochrane | RR 0.28 [0.13, 0.6] | 1 study · 161 participants | Moderate |
Summary of findings table ‐ Moxibustion plus usual care vs usual care Cord blood pH less than 7.1 · breech presentation Cephalic version by moxibustion for breech presentation (2023) · Cochrane | RR 3 [0.32, 28.38] | 1 study · 212 participants | Low |
Summary of findings table ‐ Moxibustion plus usual care vs usual care Adverse events · breech presentation Cephalic version by moxibustion for breech presentation (2023) · Cochrane | RR 48.33 [3.01, 774.86] | 1 study · 122 participants | Very low |
Summary of findings table ‐ Moxibustion plus usual care vs sham moxibustion plus usual care Non‐cephalic presentation at birth · breech presentation Cephalic version by moxibustion for breech presentation (2023) · Cochrane | RR 0.74 [0.58, 0.95] | 1 study · 272 participants | Moderate |
Summary of findings table ‐ Moxibustion plus usual care vs sham moxibustion plus usual care Need for ECV ‐ not reported · breech presentation Cephalic version by moxibustion for breech presentation (2023) · Cochrane | no estimate extracted | NR | No studies |
Treatment of eclampsia: loading dose alone vs loading dose plus maintenance dose regimen Recurrence of convulsion · women with eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | RR 4.32 [0.21, 87.18] | 1 study · 80 participants | Very low |
Treatment of eclampsia: lower‐dose regimens vs standard‐dose regimens Death of the baby before discharge: perinatal death: lower dose versus Pritchard regimen · women with eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | RR 1.52 [0.57, 4.1] | 1 study · 72 participants | Very low |
Treatment of eclampsia: lower‐dose regimens vs standard‐dose regimens Maternal death · women with eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | RR 0.28 [0.03, 2.58] | 1 study · 72 participants | Very low |
Treatment of eclampsia: lower‐dose regimens vs standard‐dose regimens Other neonatal morbidity · women with eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Treatment of eclampsia: IV maintenance vs standard IM maintenance regimen Recurrence of convulsions · women with eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | RR 0.87 [0.28, 2.72] | 1 study · 137 participants | Very low |
Treatment of eclampsia: IV maintenance vs standard IM maintenance regimen Severe morbidity · women with eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Treatment of eclampsia: IV maintenance vs standard IM maintenance regimen Side effects · women with eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Treatment of eclampsia: IV maintenance vs standard IM maintenance regimen Death of the baby before discharge: stillbirth · women with eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | RR 0.87 [0.28, 2.72] | 1 study · 137 participants | Very low |
Treatment of eclampsia: IV maintenance vs standard IM maintenance regimen Death of the baby before discharge: neonatal death · women with eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | RR 0.75 [0.25, 2.24] | 1 study · 137 participants | Very low |
Treatment of eclampsia: IV maintenance vs standard IM maintenance regimen Maternal death · women with eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | RR 0.35 [0.04, 3.27] | 1 study · 137 participants | Very low |
Treatment of eclampsia: IV maintenance vs standard IM maintenance regimen Other neonatal morbidity · women with eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Treatment of eclampsia: loading dose alone vs loading dose plus maintenance dose regimen Severe morbidity · women with eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Treatment of eclampsia: duration of postpartum maintenance regimen: short vs 24 hours after delivery Recurrence of convulsions · women with eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | 1 study · 120 participants | Very low |
Treatment of eclampsia: duration of postpartum maintenance regimen: short vs 24 hours after delivery Severe morbidity: renal failure · women with eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | 1 study · 120 participants | Very low |
Treatment of eclampsia: duration of postpartum maintenance regimen: short vs 24 hours after delivery Side effect: respiratory failure · women with eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | 1 study · 120 participants | Very low |
Treatment of eclampsia: duration of postpartum maintenance regimen: short vs 24 hours after delivery Side effect: nausea · women with eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | RR 0.14 [0.02, 1.13] | 1 study · 120 participants | Very low |
Treatment of eclampsia: duration of postpartum maintenance regimen: short vs 24 hours after delivery Side effect: flushing · women with eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | RR 0.27 [0.08, 0.93] | 1 study · 120 participants | Low |
Treatment of eclampsia: duration of postpartum maintenance regimen: short vs 24 hours after delivery Death of the baby before discharge from hospital · women with eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Treatment of eclampsia: duration of postpartum maintenance regimen: short vs 24 hours after delivery Maternal death · women with eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Treatment of eclampsia: duration of postpartum maintenance regimen: short vs 24 hours after delivery Other neonatal morbidity · women with eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Prevention of eclampsia: loading dose alone vs loading dose + maintenance regimen Eclampsia · women with pre‐eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | RR 2 [0.61, 6.54] | 2 studies · 462 participants | Low |
Prevention of eclampsia: loading dose alone vs loading dose + maintenance regimen Severe morbidity · women with pre‐eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Treatment of eclampsia: loading dose alone vs loading dose plus maintenance dose regimen Side effects · women with eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Prevention of eclampsia: loading dose alone vs loading dose + maintenance regimen Side effects · women with pre‐eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Prevention of eclampsia: loading dose alone vs loading dose + maintenance regimen Death of the baby before discharge: perinatal death · women with pre‐eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | RR 0.5 [0.19, 1.36] | 2 studies · 462 participants | Low |
Prevention of eclampsia: loading dose alone vs loading dose + maintenance regimen Death of the baby before discharge: stillbirth · women with pre‐eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | RR 0.17 [0.02, 1.3] | 1 study · 60 participants | Very low |
Prevention of eclampsia: loading dose alone vs loading dose + maintenance regimen Neonatal death · women with pre‐eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | RR 0.63 [0.27, 1.46] | 2 studies · 462 participants | Low |
Prevention of eclampsia: loading dose alone vs loading dose + maintenance regimen Maternal death · women with pre‐eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | 2 studies · 462 participants | Very low |
Prevention of eclampsia: loading dose alone vs loading dose + maintenance regimen Other neonatal morbidity · women with pre‐eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Prevention of eclampsia: IV maintenance vs standard IM maintenance regimen Eclampsia · women with pre‐eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | 1 study · 17 participants | Very low |
Prevention of eclampsia: IV maintenance vs standard IM maintenance regimen Severe morbidity · women with pre‐eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Prevention of eclampsia: IV maintenance vs standard IM maintenance regimen Side effects · women with pre‐eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Prevention of eclampsia: IV maintenance vs standard IM maintenance regimen Death of the baby before discharge: stillbirth · women with pre‐eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | RR 0.37 [0.02, 7.99] | 1 study · 17 participants | Very low |
Treatment of eclampsia: loading dose alone vs loading dose plus maintenance dose regimen Death of the baby before discharge from hospital · women with eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Prevention of eclampsia: IV maintenance vs standard IM maintenance regimen Maternal death · women with pre‐eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Prevention of eclampsia: IV maintenance vs standard IM maintenance regimen Other neonatal morbidity · women with pre‐eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | no estimate extracted | NR | No studies |
Prevention of eclampsia: short vs standard maintenance regimen (subgroups by type of short regimen) Eclampsia · women with pre‐eclampsia Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia (2023) · Cochrane | RR 1.99 [0.18, 21.87] | 4 studies · 1713 participants | Low |